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Time lapse confocal microscopyAmong the different mechanisms invoked to explain the beta cell mass expansion during postnatal stages
and adulthood, self-replication is being considered the major cellular event occurring both under
physiological conditions and in regenerating pancreas after partial pancreactomy. Neogenesis, i.e.
differentiation from pancreatic progenitors, has been demonstrated to act concurrently with beta cell
replication during pancreatic regeneration. Both phenomena have been largely elucidated in higher
vertebrates (mouse, rat and guinea pig), but an extensive description of beta cell dynamics in other animal
models is currently lacking. We, therefore, explored in zebraﬁsh the cellular origins of new beta cells in both
adult and larval stages. By integrating the results from in vivo time lapse analysis and immunostaining, we
provide a detailed reconstruction of the major processes involved in ﬁsh beta cell genesis and maintenance.
Moreover, by establishing the selective ablation of proliferating beta cells, through the ganciclovir-HSVTK
system, we could show that in larval stages self-replication is the main mechanism of beta cells expansion.
Since the same mechanism of proliferation has been observed to occur during early and late life stages, we
suggest that zebraﬁsh larvae can be used as an alternative tool for an in vivo exploration and screening of
new potential mitogens speciﬁcally targeting beta cells.© 2009 Elsevier Inc. All rights reserved.IntroductionOver the last few years a great effort has been spent from several
investigators to improve the current knowledge on postnatal
pancreatic beta cell dynamics.
In rodents, which have been enrolled as themajor animalmodels in
the ﬁeld of pancreas development, two mechanisms, i.e. neogenesis
from pancreatic ducts and intraislet replication, have been alterna-
tively postulated for the postnatal beta cell mass expansion (Yesil and
Lammert, 2008). However, a careful examination of literature suggests
that both mechanisms seem to occur in humans and rodents (Hanley
et al., 2008). According to the supporters of the “neogenesis model”, a
niche of differentiating beta cell precursors contributing to beta cell
mass increase in late life stages, is located in the pancreatic duct
epithelium (Bonner-Weir et al., 2004; Bonner-Weir and Sharma, 2006;
Inada et al., 2008). More recently, experimental evidences have been
provided, after duct ligation, supporting the recruitmentof progenitors
for beta cell mass expansion in adulthood (Xu et al., 2008).
Conversely, the replicating model proposed in several recent
investigations states that in physiological conditions beta cells self-
expand slowly while beta cell proliferation rates increase after partial
pancreactomy or streptozotocin administration (Dor et al., 2004; Teta
et al., 2005, 2007; Nir et al., 2007). Evidences that beta cell self-nton).
l rights reserved.duplication becomes the predominant mechanism in adult stages
have been elegantly reported recently by genetic lineage tracing
experiments (Dor et al., 2004; Teta et al., 2007). The molecular
mechanisms for postnatal beta cell growth are currently under
investigation and new key molecules have been shown to control
the transition of beta cells from quiescence to replication (Cozar-
Castellano et al., 2006). Moreover, several knock outmodels have been
generated that speciﬁcally address the role of cell cycle associated
proteins in the proliferation of differentiated beta cells (Rane et al.,
1999; Wang et al., 2003; Georgia and Bhushan, 2004).
Multiple studies performed in the past few years have demon-
strated that beta cell proliferation rates can be enhanced in response
to different growth factors as well as in conditions of mechanically or
chemically induced pancreatic injury (Vasavada et al., 2006).
Although many investigators, using incorporation experiments, have
reported several evidences of beta cell proliferation, it remains
debatable whether in physiological conditions terminally differen-
tiated beta cells are able to divide or need to dedifferentiate to enter
the cell cycle. The empirical distinction between these two alternative
possibilities is hampered by the low rate of beta cell replication, which
in rats drops from 18% new cells per day in the perinatal period to
about 0.5% in the adulthood (Teta et al., 2005).
An emerging need of developing suitable animal models to
uncover the beta cell growth machinery has come up. In this context,
the teleost ﬁsh Danio rerio has become a new biological system to
achieve this goal. The beta cell compartment was originally described
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cells at the 12-somite stage (Argenton et al., 1999; Biemar et al., 2001;
Huang et al., 2001; Field et al., 2003). According to a ﬁnely regulated
differentiation program, early undifferentiated endodermal cells start
to express a cascade of transcription factors before evolving into
functional beta cells (Chung and Stainier, 2008; Edlund, 2001; Ober et
al., 2003). In a previous three-dimensional reconstruction of the
zebraﬁsh pancreatic islet performed by Huang et al. (2001), the
primary islet mass was reported as a ﬂattened layer of about 12 cells at
24 hpf, which expands from day 3 post fertilization. A large body of
literature dissecting the genetic mechanisms and transcription factors
governing embryonic beta cell generation, has been produced (Huang
et al., 2001; Chung and Stainier, 2008; Dong et al., 2008; Kinkel et al.,
2008). However, little is known about the cellular events regulating
the expansion of beta cells during larval stages. Few years ago, Yee et
al. (2001) through BrdU incorporation experiments suggested that
beta cell proliferation does not take place during larval stages both in
wild type larvae and pdx1-morphants. More recently, experimental
evidences of beta cell proliferation came up with BrdU immunostain-
ings in a ﬁsh transgenic model of beta cell regeneration (Pisharath et
al., 2007). Given these two alternative hypothesis, we tried to fulﬁll
this incomplete knowledge by analyzing the beta cell mass expansion
in zebraﬁsh at different life stages through the application of several
methodologies.
To accomplish this task, we tested whether replicating beta cells
are found in zebraﬁsh larvae and adults by BrdU and PCNA
immunostaining. To further support our observations that beta cell
proliferation accounts for beta cell mass expansion also in zebraﬁsh,
we created a zebraﬁsh model of conditional beta cell ablation, which
express a Thymidine Kinase-Green Fluorescent Protein (TKGFP)
chimera under the control of the insulin promoter(Tg(-1.2ins:
TKGFP)). Through the conditional administration of the prodrug
Ganciclovir, we have been able to target and ablate the replicating
fraction of the beta cell population during larval stages. Moreover, by
whole mount time lapse analysis on Tg(-1.2ins:TKGFP) larvae, we
could also succeed in monitoring in vivo beta cell mitosis.
The analysis of neogenesis during larval stages and late adulthood
was ﬁnely assessed by both RT-PCR on handpicked islets and time
lapse confocal microscopy on double transgenics Tg(-3.5nkx2.2a:GFP)
ia3/Tg(-1.2ins:DsRed).
Our results in zebraﬁsh corroborate the recently discovered
prominent role of beta cell replication among the mechanisms
involved in the vertebrate age-related beta cell mass maintenance
and provide strong efforts to consider the zebraﬁsh as a suitable tool
to explore beta cell biology.
Results
BrdU labeling of pancreatic beta cells in adult zebraﬁsh
Considering that short-term bromodeoxyuridine (BrdU) labeling
was previously exploited to estimate beta cell proliferation inmice (Teta
et al., 2005), while long-term labeling may impair beta cell replication
(Chen et al., 2007), we performed a 4 h BrdU challenge in adult ﬁsh at
different life stages (from 5 to 9months). According to the high number
of BrdUpositive cells in the intestinal crypts (Fig.1A),we considered our
protocol suitable for the identiﬁcation of proliferating cells.
After a 4 h BrdU-treatment, we found in beta cells an incorporation
rate ranging from 0.22±0.01 (n=3) at 5 months to 0.03±0.01%
(n=5) at 9 months, implying β-cell proliferation rates in a 24-h
period of 1.3 and 0.2%, respectively (Figs. 1B–E). Comparably low
proliferation rates of adult beta cells were also conﬁrmed by PCNA
immunostaining (Fig. 1D).
To establish whether low proliferation rates were a characteristic
common to all hormone secreting cells of the adult pancreatic islets,
BrdU was co-immunodetected with insulin-glucagon-somatostatinantisera. We found very rare proliferating alpha and delta cells
(Fig. 1F), supporting the idea that adult islet hormone secreting cells
are mostly quiescent. Notably, we found many proliferating hormone
negative cells in adult pancreatic islets (Fig. 1G), in agreement with
previous observations in mice (Teta et al., 2005).
The ﬁrst primary islet emerges through differentiation of precursor
cells and expands by replication of newly formed beta cells
The zebraﬁsh pancreas develops from two separate buds, ﬁrst a
posterior one at 20 hpf originating endocrine tissue and then an
anterior one emerging at 34 hpf that eventually fuse with the ﬁrst and
generates exocrine and endocrine tissues (Field et al., 2003; Zecchin et
al., 2004). To determine the dynamics of early primary islet formation,
we performed a series of ﬂuorescent confocal microscopy analysis
during early stages of development. We ﬁrst screened Tg(-1.2ins:GFP)
ﬁsh at the time of appearance of beta cells, from 20 to 25 hpf. Despite
the fact that we could easily observe and continuously follow the
increase of insulin-expressing cells, these appeared by differentiation
from precursors rather than by division of an already differentiated
beta cell; no obvious mitosis of beta cells could be seen (Fig. 2A1–A8
and Supplemental Movie 1).
Previous studies carried out by BrdU incorporation have shown
controversial results on the mechanisms regulating beta cell expan-
sion during larval stages (from 48 hpf to 120 hpf) (Yee et al., 2001;
Pisharath et al., 2007). More recently, Pisharath and colleagues have
demonstrated in 120 hpf larvae the occurrence of replicating insulin-
expressing cells in both physiological conditions and after a drug-
mediated beta cell ablation. To assess whether the proliferation of beta
cells contribute to the expansion of the ﬁrst bulk of beta cells, we
performed whole mount double immunostaining with insulin and
PCNA antibodies, the latter being a marker for cells in early G1 and S
phases of the cell cycle. In agreement with a replicatingmodel for beta
cell expansion, we found at least one PCNA-positive beta cell in 11 out
of 77 analyzed larvae at 48 hpf (Fig. 2B1, B2). However, at 7 days post
fertilization, the ratio of PCNA-insulin coexpressing cells decreased to
one PCNA-positive beta cell in 3 out of 57 screened larvae. The
presence of proliferating beta cells was conﬁrmed by a phosphohis-
tone (PH3)-insulin co-immunostaining on age-matched larvae (data
not shown).
Selective beta cell conditional ablation through ganciclovir
(GCV) treatment
To conﬁrm our observations on the proliferation of beta cells
during larval stages, we established a new system of conditional cell
ablation in zebraﬁsh, based on the expression of a HSV-TKGFP
transgene under the control of the insulin promoter and the
administration of the prodrug ganciclovir (GCV).
We ﬁrst generated a vector expressing a chimeric fusion protein
between TK and GFP (TKGFP) under the control of a CMV promoter
and transfected into NIH 3T3 ﬁbroblasts.
As shown in Fig. 3A, cell expressing the fusion construct displayed
a nuclear speciﬁc green ﬂuorescent signal, as expected (Loimas et al.,
1998), thus suggesting a proper distribution and expression of the
chimeric protein. In agreementwith previous results, the TK activity of
the fusion protein was normal (data not shown).
We next generated a stable transgenic line expressing the fusion
protein TKGFP under the control of a 1.2 kb insulin promoter
(Tg(-1.2ins:TKGFP)). All Tg(-1.2ins:TKGFP) embryos exhibited a loca-
lized green ﬂuorescent signal at the level of the third somite, ventral to
the notochord, in the region corresponding to the dorsal bud of the
endocrine pancreas (Fig. 3B). In order to check the correct localization
of the ﬂuorescent signal in the beta cell compartment, 20 dpf
transgenic larvae were ﬁxed, and parafﬁn sections were stained
using a red ﬂuorescent conjugated anti-insulin antiserum. Green
Fig. 1. (A) Representative histology of pancreatic and gut tissue immunostained with antibodies against insulin (green) and BrdU (red). As expected, criptae of the gut, at the bottom,
are strongly positive for BrdU. (B, C, E) Pancreatic islets from 9months (B and E) and 5months old ﬁsh (C) immunostained for insulin (green) and BrdU (red) and counterstainedwith
DAPI (blue). White arrowheads indicate insulin and BrdU copositive cells. (D) Proliferation of beta cells, although at a low rate, was also conﬁrmed by PCNA immunostaining as
indicated by the arrowhead. (F) Histology of proliferating alpha/delta cells within an islet stained with antibodies against glucagon and somatostatin (cytoplasmic red). A white
arrowhead indicates a glucagon/somatostatin producing cell copositive for BrdU (light nuclear red). (G) Representative pancreatic section showing a proliferating hormone negative
cells (white arrowhead). Scale bar: 100 μm.
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insulin in the cytoplasm, allowing us to evaluate the beta cell speciﬁc
expression of the chimeric protein (Fig. 3C). Confocal microscopy
analysis of Tg(-1.2ins:TKGFP) ﬁsh performed at different developmen-
tal stages between 24 h and six days (Figs. 3D–F and Supplemental Fig.
1A) displayed a time-dependent increase of beta cell nuclei.
A preliminary GCV toxicity analysis was carried out in wild type
zebraﬁsh following a treatment of six days with concentration ranges
from 0 to 120mg/l. Neither signs of toxicity nor evident disturbances in
feeding and behaviour were observed in any of the treated larvae even
one week after the prodrug administration. According to a recently
described application in transgenic mice (Heppner et al., 2005), a
30mg/l dosewas considered for the beta cell ablation experiments. GCV
was directly applied in the ﬁsh water from the blastula stage.
By examination under confocal microscopy at 7 days post
fertilization (dpf), GCV-treated larvae displayed a mean number of
30±2 beta cells (n=20). A group of age-matched untreated larvae
was used as control and by confocal analysis a mean number of 40±1
beta cells was identiﬁed (n=18). Thus, a statistically signiﬁcant
reduction of approximatively 25% in the total number of counted betanuclei was observed in the treated group (t-test; pb0.02) (Figs. 4A–
C). Moreover, beta cell speciﬁc apoptosis was observed after prodrug
treatment (Figs. 4D and E). Prolonged exposure of a separate group of
30 larvae to the drug and increasing concentrations of GCV did not
alter these results (data not shown). To exclude random ﬂuctuations
in cell numbers, independent measurements were performed on
several larvae and in different treatments. In order to prevent any TK-
independent inﬂuence of the drug on the zebraﬁsh pancreas,
transgenic ﬁsh expressing the GFP under the insulin promoter were
treated with GCV at the concentration of 30 mg/l. A group of age-
matched, untreated Tg(-1.2ins:GFP) transgenic larvae was used as
controls. No obvious reduction in the total number of ﬂuorescent cells
was observed in the GCV-treated larvae compared to untreated
controls (data not shown).
The bystander effect has been reported to induce a GCV-mediated
apoptosis in neighboring cells that do not express the TK (Crum-
packer, 1996). This neighboring cell death was observed in many in
vitro and in vivo experiments, however, its mechanism and penetrance
are still controversial (Andrade-Rozental et al., 2000). To address
whether our conditional beta cell ablation could also affect
Fig. 2.Generation of insulin-expressing beta cells during embryonic and larval stages. (A) Fig. A1 to A8 are projections of confocal stacks recorded every 30min from a dorsal view of a
representative 20–25 hpf ins:GFP transgenic embryo. The whole movie (39 stacks, 5 hrs) can be seen in the Supplemental Movie 1. (B1, B2) Immunoﬂuorescence with a anti-PCNA
(red) and anti-insulin (green) on 48 hpf larva. Proliferating beta cells are indicated by an arrowhead.
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hybridization and immunoﬂuorescence in untreated (n=30) and
GCV-treated Tg(-1.2ins:TKGFP) larvae (n=30) using either a glucagonFig. 3. In vitro and in vivo analysis of chimeric TKGFP protein expression. (A) Fluorescencemicro
successfully transfecteddisplay a highly intense nuclearﬂuorescent signal. Fluorescent cellswer
a 72 hpf stable Tg(-1.2ins:TKGFP) zebraﬁsh. The green ﬂuorescent beta cell nuclei of the islet are
signal in beta cells. Confocal image of a representative immunoﬂuorescencewith anti-insulin an
nuclei and insulin staining (red) is depicted. (D–F) Confocalmicroscopy images of GFP expressi
the GFP in the nucleus with a strong speciﬁc signal. Each image is a superimposed projection oantisense riboprobe or an anti-glucagon antiserum. As depicted in
Figs. 4F–I, we could not observe neither a reduction in glucagonmRNA
nor in the number of alpha cells in the group of GCV-treated larvaescopy image of NIH 3T3murineﬁbroblasts transfectedwith the plasmid pCS2-TKGFP. Cells
e visualized and photographed 24 h after transfection. (B) Fluorescentmicroscopy image of
indicated by an arrow. (C) Tg(-1.2ins:TKGFP) embryos exhibit a nuclear speciﬁc ﬂuorescent
d anti-GFP antibodies on 20 dpf Tg(-1.2ins:TKGFP) larvae. A representative islet with green
on in living Tg(-1.2ins:TKGFP) embryos at different developmental stages. Beta cells express
f a 0.1 mm scanning. (D) 24 hpf; (E) 48 hpf; (F) 6 days.
Fig. 4. Decrease in the number of beta cell ﬂuorescent nuclei and quantitative analysis of bystander effect in Tg(-1.2ins:TKGFP) larvae treated with Ganciclovir. (A) Tg(-1.2ins:TKGFP)
larvae have a decreased number of beta cells when treated with GCV (right, gray column) compared to untreated controls (left, white column); a comparable amount of larvae
(+GCV n=20; controls, n=18) was analyzed in repeated experiments. (B, C) Projection of a confocal stack image in a representative untreated (B) and GCV treated (C) larva after
7 days of prodrug administration. Scale bar: 10 µm. (D, E) Beta cell speciﬁc apoptosis after ganciclovir treatment. Representative double immunostaining of pancreatic tissue with
cleaved-caspase 3 (red) and insulin (green) antisera. The apoptotic beta cell is marked by an arrowhead. (F, G) Comparison of an untreated (D), and a treated group of 7 days larvae
(E) for their glucagon expression as revealed by in situ hybridization; glucagon mRNA levels are not affected by the GCV treatment indicating an absence of bystander effect. (H, I)
Representative confocal projections of GCV-untreated (E) or GCV-treated larvae (F) displaying a comparable number of ﬂuorescent alpha cells detected with an anti-glucagon
antiserum (in red). The nuclei of beta cells expressing TKGFP (in green) are decreased in number in GCV-treated larvae. (J) Table comparing the number of alpha and delta cells in the
pancreas of 5dpf Tg(-1.2ins:TKGFP) embryos treated with the prodrug and showing non signiﬁcant differences with controls. (K, L) Representative pictures of embryos untreated (K)
or treated (L) with ganciclovir and stained for nuclei (blue, DAPI) or somatostatin and glucagon (red).
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for glucagon and somatostatin in parafﬁn embedded pancreatic tissue
of GCV-treated larvae (Figs. 4J–L). Thus, we could rule out a
statistically signiﬁcant bystander effect causing non-beta cell death
in GCV-treated transgenic ﬁsh.
Insulin-expressing cells replicate at larval stages
As the GCV-TK mediated ablation has been shown to kill only
dividing cells (Borrelli et al., 1988) we attempted to support the GCV-
mediated decrease of beta cells with observation of living mitosis. To
this purpose, we screened by time lapse confocal microscopy the
pancreas of untreated Tg(-1.2ins:TKGFP) ﬁsh for dividing cells
expressing GFP. Given the slow replication rate of beta cells, we
carried out a 12 h confocal time lapse analysis monitoring the growth
of the islet from 48 h on living transgenic larvae. A 0.1 mm depth
scanning was recorded every 20 min. By a Z-stacks reconstruction wehave been able to identify insulin-expressing cells during their mitosis
(Fig. 5C1–C8 and Supplemental Movie 2).
In order to characterize the rate of beta cell replication during
larval stages, we have performed beta cell nuclei counting through
confocal analysis in the ﬁrst week of development (n=10). As
depicted in Supplemental Fig. 1A, we have obtained a linear growth in
the overall number of beta cell nuclei, with on average a daily 15%
increase in the number of beta cells.
Differentiation of ductal cells into beta cells occurs with low frequency
during larval stages, but in adulthood does not seem to be the major
mechanism for beta cell maintenance
Ductal cells have been previously pointed as an alternative source
of new beta cells during mouse postnatal and adult stages (Bonner-
Weir et al., 2004; Inada et al., 2008). In a previous report it has been
suggested that endocrine progenitors may lie in the pancreatic duct or
Fig. 5. Generation of insulin-expressing beta cells by self-duplication. C1–C8 are projections of confocal stacks recorded every 20 min from a dorsal view of a 48 hpf larva. A double
concomitant mitosis is clearly visible on the bottom left (white arrowheads). A reconstructed movie can be seen in the Supplemental Movie 2.
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advantage of the Tg(-3.5nkx2.2a:GFP)ia3 line (Pauls et al., 2007) by
crossing it with Tg(-1.2ins:DsRed). By using ﬂuorescent confocal
microscopy we carried out several confocal analysis in 6 to 30 dpf
double transgenic larvae (n=25). The starting age was chosen when
the primary islet is already formed, while isolated beta cells start to
appear more caudally, along the pancreatic duct. In a small number of
our 6 dpf transgenics we could document the appearance of single
beta cells among the nkx2.2a positive cells of the duct (Fig. 6A). We
continued to screen the larvae by monitoring and scoring them every
day. At 17 dpf some larvae had two isolated beta cells and by 22 dpf
they represented the bigger fraction of larvae (Fig. 6B). Moreover,
larvae with three or more isolated beta cells in the duct region
appeared, rarely, at 15 dpf and they were a relevant fraction of larvae
at 30 dpf (Fig. 6C). Notably, by 30 dpf, we could ﬁnd pairs of red
ﬂuorescent cells along the duct epithelium, suggesting a secondary
wave of replication of beta cells (Fig. 6D). The extent at which duct-
associated beta cell appears along the pancreatic duct in the ﬁrst
30 days of ﬁsh life is summarized in Supplemental Fig. 1B and
Supplemental Table 2.
Finally, we examined whether ngn3, a marker of early endocrine
precursors (Mellitzer et al., 2004), is expressed in adult pancreatic
islets. Zebraﬁsh Ngn3 orthologue transcripts can be detected in a
very limited period within the ﬁrst days of development (Zecchin et
al., 2007). To test whether ngn3 expression during adult stages marks
the differentiation of new beta cells through the recapitulation of an
early developmental pathway, we extracted and pooled fresh
pancreatic islets from different 6 months (n=4) and 9 months old
(n=3) Tg(-1.2ins:GFP) transgenic ﬁsh, separating them into primary
and secondary islets. We then performed RT-PCR for several
transcription factors, including ngn3, using a high number of PCR
cycles (45) to amplify also rare transcripts (Fig. 7). In repeated
experiments we could not obtain ngn3 speciﬁc ampliﬁcation,
supporting the idea that differentiation of early endocrine precursors
does not represent a major mechanism involved in pancreatic beta
cell maintenance. In agreement with this result, we never detected
insulin-expressing ductal cells in all the pancreatic sections immu-
nostained with insulin-BrdU antisera (data not shown).
Discussion
A fundamental axiom in cell biology is that increasing glucose
metabolic demands require an elevated insulin secretion from
pancreatic beta cells. Consequently, the pancreatic beta cell mass
increases during early life stages and is maintained in adulthood to
fulﬁll the insulin need. Inadequate insulin secretion or action,observed in type I and type II diabetes, respectively, is often associated
to a reduced beta cell mass (Wajchenberg, 2007). One of the current
therapeutical approaches to type I diabetes is based on the develop-
ment of drugs or genetic tools aimed to increase beta cell mass
(Lipsett et al., 2006; Limbert et al., 2008).
In this paper we undertook the analysis of beta cell dynamics
during different life stages in the vertebrate teleost, D. rerio, which has
recently become an alternative attractive model in the analysis of
pancreatic development (Biemar et al., 2001; Field et al., 2003; Dong
et al., 2008). The choice of this vertebrate model was supported by the
concept that adult beta cell growth and regeneration should mirror
and recapitulate embryonic beta cell development. To accomplish this
evaluation, we ﬁrst examined if the recently reported model of beta
cell self-renewal during adult stages is well conserved in our ﬁsh
model. To address this issue, we labeled several ﬁsh at various adult
stages with BrdU and performed double immunoﬂuorescence using
insulin and BrdU antisera. Our results conﬁrm the notion that beta cell
turnover during adulthood follows a “slow replicating model” and
aged beta cells are almost in a quiescent state (Teta et al., 2005). In
several pancreatic sections we also observed many proliferating
hormone negative cells inside the islets which were already detected
in mouse by Teta et al. (2005). These proliferating cells could be the
previously reported nonendocrine pancreatic cells, NEPCs, which, in
vitro, have been shown to be able to transdifferentiate into functional
beta cells (Hao et al., 2006).
Our data provided a basis to assume that similar mechanisms of
beta cell proliferation should occur during larval growth and adult
stages in order to allow islet mass expansion. Indeed, the funda-
mental role of proliferation for postnatal beta cell mass growth has
been already largely discussed in rodents (Cozar-Castellano et al.,
2006).
Using two distinct transgenic ﬁsh, Tg(-1.2ins:GFP) and Tg(-1.2ins:
TKGFP), we investigated the major cellular events contributing to the
early pancreatic islet aggregation. To this purpose, we monitored by
confocal microscopy a group of transgenic zebraﬁsh expressing the
green ﬂuorescent protein under the insulin promoter during the ﬁrst
hours of beta cell differentiation. These genetically encoded lineage
tracing experiments allowed us to conﬁrm the hypothesis that a
population of progenitor cells during embryogenesis generates the
ﬁrst bulk of beta cells. The aggregation of newly forming scattered
beta cells into a single islet has been previously documented in
zebraﬁsh (Biemar et al., 2001; Kim et al., 2005).
To address the role of self-replication in the genesis of new beta
cells during larval stages, we performed whole mount coimmunos-
tainings with insulin and PCNA antibodies on 48 hpf and 7 dpf larvae.
Based on repeated confocal ﬂuorescent analysis, we found several beta
Fig. 6. Differentiation of nkx2.2-expressing duct cells into insulin-expressing cells occurs in the intrapancreatic duct during larval stages. (A–D) Projections of confocal stack images at
different larval stages of Tg(-3.5nkx2.2a:GFP)ia3/Tg(-1.2ins:dsRed) ﬁsh. Single focal plans of channels red, green and their overlay are represented at the bottom of each panel. In panel
B the small arrow indicates the budding of an insulin-expressing cell from the duct. (C) Budding of two new insulin-expressing cells (arrows) occurring with a concomitant division
of an insulin-expressing cell (arrowheads). (D) Pairs of insulin-expressing cells lie among nkx2.2a-expressing duct cells (arrowheads).
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Fig. 7. RT-PCR analysis of handpicked islets from zebraﬁsh at different developmental
stages. N: Negative control; 5 dpf and 7 dpf: pooled islets at larval stages; 5P and 5S:
pooled primary and secondary islets, respectively, from 5 months old ﬁsh; 9P and 9S:
pooled primary and secondary islets, respectively, from 9 months old ﬁsh. C: Pooled
whole embryos (n=50) at 3 dpf.
306 E. Moro et al. / Developmental Biology 332 (2009) 299–308cells immunostained for PCNA, indicating the existence of a subset of
beta cells at G1–S transition.
To further conﬁrm that proliferating beta cells are involved in islet
expansion during larval stages, we generated transgenic ﬁsh
expressing a TKGFP chimeric protein under control of the insulin
promoter. The advantages of this transgenic model lie on the
possibility to apply the GCV/TK conditional “suicide”, which
speciﬁcally targets proliferating cells and to obtain a highly speciﬁc
nuclear ﬂuorescent signal in beta cells, allowing to precisely assess
the total number of beta cells.
This drug-mediated approach represents a valid alternative to the
recently reported model of conditional ablation based on E. coli
Nitroreductase (Curado et al., 2007; Pisharath et al., 2007). In two
independent investigations the substrate metroinidazole (MTZ) was
shown to be toxic above a concentration of 10 mM, particularly in
adult stages (Pisharath et al., 2007). On the other hand, GCV, even at
dose of 120 mg/l (4 times higher than the one used in this study) was
not toxic, nor it induced phenotypic alterations after two weeks of
treatment. GCV was given to a group of Tg(-1.2ins:TKGFP) ﬁsh for
several days and their total number of beta cells was evaluated at the
end of the treatment. A signiﬁcant reduction of the beta cell
population was obtained in the group of transgenic larvae treated
with the prodrug when compared to a matched number of untreated
ﬁshes. Such decrease of the total number of beta cells was pointing to
the existence of a proliferating beta cell compartment in the primary
islet. Relying on the highly ﬂuorescent nuclear signal detected in the
beta cell of Tg(-1.2ins:TKGFP) ﬁsh, we sought for beta cells in active
mitosis using live imaging of ﬁsh larvae. By time lapse confocal
microscopy we were able for the ﬁrst time to track and directly follow
beta cells during a mitotic process (Supplemental Movie 2). These
experiments enabled us to conclude deﬁnitively that beta cell
proliferation contributes to the pancreatic mass expansion, similarly
to higher vertebrates. During the GCV treatment we have not been
able to measure a signiﬁcant increase in beta cells appearance along
the pancreatic duct (Supplemental Fig. 1C), suggesting that differ-
entiation from precursors does not account for beta cell recovery after
prodrug-mediated beta cell injury. As our ablation is only partial (25%
of the total), this result is not in contrast with the observations of
Pisharath et al. (2007), which described the appearance of newly
formed beta cells from adjacent regions, after total, NTR-mediated
ablation. We can hypothesize that only a more severe injury is able to
stimulate the proliferation/differentiation of quiescent precursors, as
seen after duct ligation in mice (Xu et al., 2008).We also tried to establish whether differentiation of ductal cells
into beta cells contributes to the early beta cell mass increase. To this
purpose, we used the Tg(-3.5nkx2.2a:GFP)ia3/Tg(-1.2ins:dsRed) line,
which represents a new tool to simultaneously track ductal and beta
cell dynamics. We examined different larvae up to 30 dpf under
confocal microscopy, and we were able to detect both duct cells
differentiating into beta cells and duct-associated beta cells after a cell
division. However, the rate at which beta cells were found to be
positive for nkx2.2a, thus deriving from transdifferentiation of duct
cells, was much lower than the rate of beta cell proliferation at
5 months, measured by BrdU/PCNA immunostaining.
We have also examined the expression of Ngn3 in handpicked
adult islets by RT-PCR at high number of cycles. Activation of Ngn3
expression is a widely accepted marker of islet cell progenitors, which
has been shown to indicate beta cell differentiation triggering after
pancreatic injury (Xu et al., 2008). On pooled pancreatic islet from
several adult ﬁsh we have been able to demonstrate amplicons for the
major transcription factors (neuroD and nkx2.2) involved in beta cell
differentiation and maintenance. Indeed, we could never detect
amplicons for Ngn3, indicating that beta cell progenitors are probably
very rare in adult stages and do not account for the adult beta cell
massmaintenance. This result perfectly agrees with the current model
of beta cell mass increase andmaintenance in rodents, which suggests
that beta cell proliferation is active in physiological conditions, while
beta cell differentiation accounts together with replication for islet
mass recovery after a severe pancreatic injury (Dor et al., 2004;
Brennand et al., 2007; Nir et al., 2007; Hanley et al., 2008; Xu et al.,
2008).
Our data provide additional supports to the concept that in
vertebrates beta cells are able to replicate both in early development
and in late adulthood. The model of self-replication underscores the
need of developing strategies to expand the beta cell population in
conditions where a deprivation of the total beta cell mass occurs
(i.e. type I diabetes). To this purpose, transparent zebraﬁsh larvae
can be considered a new candidate model, which may be exploited
as a tool to screen for new small chemical drugs able to enhance
beta cell replication. The combination of a high throughput screen-
ing with the availability of the Tg(ins:nfsGFP) (Pisharath et al., 2007)
and Tg(-1.2ins:TKGFP) models offers a suitable instrument to the
development of new strategies for beta cell expansion.
Experimental procedures
Plasmid constructs
Thymidine kinase cDNA was selectively ampliﬁed from pMC1TK
plasmid (kindly provided by Prof. Bonaldo (University of Padova,
Italy) by PCR using oligonucleotides Tk-1(5′-GGATCCCGTATGG-
CTTCGTAC-3′) and Tk-2 (5′-AGATCTGTTTCCGTTAGCCTC-3′). Tk-2
contains a TCC triplet which introduces a TGA to GGA substitution
in the thymidine kinase stop codon. The ampliﬁed fragment was
subcloned into PCR-blunt II-TOPO (Invitrogen) and retrieved by
EcoRI/BglII double digestion. The mmGFP coding sequence was
obtained from pG1 plasmid by a BamHI/Xba digestion. Both TK and
mmGFP fragments were religated to pG1, obtaining the construct
pG1TKGFP. The in-frame connection between the two coding
sequences was veriﬁed by sequencing on both strands. A 1.2 kb
zebraﬁsh insulin promoter sequence was further isolated from
plasmid insGFP by HindIII/BamHI digestion and subcloned to
pG1TKGFP, obtaining the construct pG1insTKGFP. All plasmids were
checked by direct sequencing.
In vitro evaluation of pG1TK correct expression
The fusion cassette TKGFP was retrieved by a EcoRI/XbaI digestion
and ligated to pCS2+ vector. NIH 3T3 murine ﬁbroblasts were grown
307E. Moro et al. / Developmental Biology 332 (2009) 299–308in Opti-MEM I medium (Gibco, Invitrogen, Italy) supplemented with
5% fetal calf serum (both from Life Technologies, Italy), 2 mM L-
glutamine, 100 units/ml penicillin (GIBCO BRL) and 100 mg/l
streptomycin at 37 °C in a 5% CO2/95% air humidiﬁed atmosphere.
Transfections were performed using Lipofectamine Reagent (Gibco,
Invitrogen, Italy). Cells (105) were seeded into 6-well plates 24 h
before the transfection. Transfection procedure was performed
according to the manufacturer's instructions. Transient expression of
the construct was assessed under ﬂuorescent microscopy (Leica,
Milan, Italy).
Generation and maintenance of transgenic zebraﬁsh
pG1insTKGFP was linearized by NsiI and dissolved in 0.25% Phenol
Red in 0.1 Tris–HCl at the concentration of 50 ng/µl. Fertilized eggs
from wild type zebraﬁsh at one cell stage were injected and about 50
embryos survived to adulthood. Transgenic zebraﬁsh were identiﬁed
by examining F1 embryos produced from random mating between
injected zebraﬁsh using ﬂuorescence microscopy (Leica MZFLIII,
Italy). Transgenic founders were outcrossed with wild type zebraﬁsh
and the resulting F2 offspring was screened under ﬂuorescent
microscopy. The zebraﬁsh lines Tg(-1.2ins:GFP) and Tg(-1.2ins:
DsRed), have been kindly provided by Prof. Wolfgang Driever. The
zebraﬁsh line Tg(-3.5nkx2.2a:GFP)ia3 has been already described
(Pauls et al., 2007).
Conditional ablation of beta cells
Fertilized eggs obtained from incross mating between Tg(-1.2ins:
TKGFP) ﬁsh lines were treated for six days in ﬁsh water containing the
GCV solution at a concentration of 30mg/l. Everyday the mediumwas
replenished in order to minimize possible artifacts due to prodrug
degradation. At day 7 treated larvae were anesthetized, embedded in
low-melting agarose and analyzed under Bio-Rad Radiance confocal
system. All images were processed with Image J software (National
Institute of Health, USA). Statistical analysis was performed with the
GraphPad Prism software.
Whole mount in situ and immunohistochemistry
A pool of untreated and GCV treated larvae at 7 dpf was collected
and stored in 4% buffered p-formaldehyde. Digoxigenin labeled-
glucagon antisense riboprobe synthesis and whole mount in situ
hybridization were performed, as previously described.
Whole mount immunohistochemistry was performed as pre-
viously described. Rabbit anti-human glucagon (1:100) (Dako),
guinea pig anti-human insulin (1:50) (Dako), rabbit anti-Phospho-
H3 (Upstate) were applied as primary antibodies. Swine anti-rabbit
IgG-TRITC (1:100) (Dako) and rabbit anti-guinea pig IgG-TRITC
(Sigma) were used as secondary antisera. Brieﬂy, larvae were ﬁxed
overnight in 4% paraformaldehyde in phosphate-buffered saline
(PBS). Fixed larvae were washed several times and permeabilized
with methanol for 1 h at −20 °C, washed again with PBS-1% Triton
X100 and incubated with primary antibody for 1 h at room
temperature and 40 h at 4 °C. After repeated washes, the incubation
with secondary antisera was carried out for 24 h at 4 °C and the larvae,
washed again, were ﬁnally mounted in 50% glycerol in PBS.
Immunohistochemistry on parafﬁn slides
Pancreatic tissue was dissected from starved or fed ﬁsh and ﬁxed
with 4% paraformaldehyde/PBS solution overnight. After dehydration
with ethanol and parafﬁn embedding, 8–10 μm slices were collected
on SuperFrost slides. Rehydratation with chloroform and ethanol was
followed by antigen heat retrieval on a steamer with citrate buffer (pH
6.0) and permeabilization with 0.2% Triton X-100, before primaryantibody incubation. Primary antisera were guinea pig anti-insulin
(Dako), rabbit anti-glucagon and anti-somatostatin (Dako), mouse
anti-PCNA (Dako), mouse anti-BrdU (Roche), anti-rabbit green
ﬂuorescent protein-Alexa Fluor 488 conjugated (Invitrogen), anti-
cleaved-caspase 3 (Cell Signalling, Italy). Secondary antibodies were
anti-mouse IgG-TRITC (Dako), anti-rabbit IgG-FITC (Dako). Nuclear
labeling was performed by 4′-6 diamino-2-phenylindole (DAPI)
(Invitrogen).
Short-term pancreatic endocrine cell proliferation analysis
For short-term BrdU labeling, eleven animals (5 to 9 month-old
ﬁsh) were intraperitoneally injected with BrdU (10 mM in NaCl pH
7.2) under tricaine anesthetization 4 h before they were sacriﬁced
(Chapouton et al., 2006). Results represent the average of eleven
animals, each with an average of 15 islets counted per animals. In silico
beta cell counting was performed using the ITCN ImageJ-plugin.
RT-PCR on freshly pooled islets
Adult Tg(-1.2ins:GFP) ﬁsh were anesthetized with tricaine and
their pancreatic tissue manually removed with sterilized needles and
microsurgery scissors and immediately placed in Trizol (Invitrogen,
Italy). Secondary islets (range between 20 and 30) were pooled and
collected togetherwith exocrine tissue. RNA extractionwas performed
according to the manufacturer's instructions. Reverse transcription
was performed in a 20 μl reaction using Superscript II Reverse
transcriptase (Invitrogen, Italy) and random hexamers, as previously
described (Pauls et al., 2007). Details of the primers used are given in
Supplemental Table 1. PCRs were repeatedly performed on pancreatic
tissue from different larvae at the reported life stages.
Image acquisition
For confocal microscopy PTU-treated larvae were embedded on
0.7% low-melting agarose and placed on a Petri capsule ﬁlled with ﬁsh
water. Using a low intensity laser (20% intensity) to minimize a laser
induced cell damage as well as photobleaching confocal stacks were
recorded on BioRadiance confocal system using 40× immersion
objective (Nikon, Italy) every 20 min. All images were ﬁrst adjusted
with Lasersharp2000 sofware and analyzed with ImageJ software
(http://rsb.info.nih.gov/ij/).
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